May 17, 2024
CDER Center for Clinical Trial Innovation (C3TI) Content current as of: 05/17/2024 Regulated Product(s) Topic(s)
May 17, 2024
Tell someone you’re a doctor, and the reaction is often: “You must be rich.” But physicians who are just finishing medical school or are in their […]
May 17, 2024
The US Department of Justice (DOJ) officially moved to reclassify marijuana as a Schedule III controlled substance on Thursday, marking a major shift in US policy […]
May 17, 2024
BASEL, Switzerland — Early reduction of blood pressure has a beneficial effect in hemorrhagic stroke but a detrimental effect in ischemic stroke, new trial data show. […]
May 17, 2024
On This Page Date: June 26, 2024 Time: 1:00 PM – 2:00 PM ET Visit CDER Small Business and Industry Assistance Page ABOUT THIS WEBINAR (Hosted […]
May 17, 2024
BRCA is no longer the only gene that identifies hereditary breast cancer (BC) syndromes. Pathogenic variants of CDH1 identify a form of hereditary lobular BC (HLBC) […]
May 17, 2024
VENICE, ITALY — Differences in how adipose tissue responds to insulin may account for why type 2 diabetes is more common in men than in women […]
May 17, 2024
Evaluating Immunosuppressive Effects of In Utero Exposure to Drug and Biologic Products – 07/11/2024
On This Page Date: July 11 – 12, 2024 Day1: Thu, Jul 11 9:00 AM – 5:00 PM ET Day2: Fri, Jul 12 9:00 AM – […]
May 17, 2024
A relatively high percentage of men in their 70s and 80s, as well those determined to have a limited life expectancy, report receiving prostate cancer screening, […]